A detailed history of Victory Capital Management Inc transactions in Pulmonx Corp stock. As of the latest transaction made, Victory Capital Management Inc holds 826,297 shares of LUNG stock, worth $5.24 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
826,297
Previous 853,846 3.23%
Holding current value
$5.24 Million
Previous $10.9 Million 29.64%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$8.71 - $14.65 $239,951 - $403,592
-27,549 Reduced 3.23%
826,297 $7.66 Million
Q4 2023

Feb 05, 2024

SELL
$7.89 - $13.14 $764,675 - $1.27 Million
-96,917 Reduced 10.19%
853,846 $10.9 Million
Q3 2023

Nov 06, 2023

SELL
$9.88 - $14.0 $262,620 - $372,134
-26,581 Reduced 2.72%
950,763 $9.82 Million
Q2 2023

Jul 27, 2023

BUY
$10.78 - $13.65 $10.5 Million - $13.3 Million
977,344 New
977,344 $12.8 Million
Q3 2022

Nov 02, 2022

SELL
$15.35 - $23.99 $3,085 - $4,821
-201 Reduced 0.78%
25,722 $429,000
Q2 2022

Aug 01, 2022

SELL
$14.0 - $27.95 $686 - $1,369
-49 Reduced 0.19%
25,923 $382,000
Q1 2022

May 04, 2022

SELL
$21.13 - $35.65 $14,727 - $24,848
-697 Reduced 2.61%
25,972 $626,000
Q4 2021

Feb 07, 2022

SELL
$29.72 - $45.1 $118,137 - $179,272
-3,975 Reduced 12.97%
26,669 $855,000
Q3 2021

Nov 02, 2021

SELL
$35.98 - $44.48 $8,599 - $10,630
-239 Reduced 0.77%
30,644 $1.1 Million
Q2 2021

Aug 03, 2021

SELL
$37.61 - $48.0 $37,647 - $48,048
-1,001 Reduced 3.14%
30,883 $1.36 Million
Q1 2021

May 04, 2021

SELL
$44.0 - $67.54 $23,496 - $36,066
-534 Reduced 1.65%
31,884 $1.46 Million
Q4 2020

Feb 01, 2021

BUY
$39.31 - $69.02 $1.27 Million - $2.24 Million
32,418 New
32,418 $2.24 Million

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.